PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Emideltide
A research peptide related to delta sleep-inducing peptide (DSIP) chemistry, marketed for its potential effects on sleep regulation and stress modulation. Human data are minimal and it remains an investigational research compound.
Sign in to rate this peptide.
Emideltide is described as a delta sleep-inducing peptide analog that is thought to influence the neuromodulatory systems governing slow-wave sleep. Like DSIP, it is proposed to interact with central pathways that promote delta-frequency EEG activity and to modulate the hypothalamic-pituitary-adrenal stress axis. The precise receptor targets remain poorly characterized, and its activity is inferred largely from the broader DSIP literature. Reported effects center on sleep architecture, stress resilience and neuroendocrine balance.